Atlas Trials

A Retrospective Study to Evaluate the Safety and Efficacy of a Nucleoside-Sparing Regimen of Darunavir, Ritonavir, and Dolutegravir

Clinical trial NCT03198884 · COMPLETED

Trial details

NCT number
NCT03198884
Sponsor
Southern Illinois Healthcare Foundation
Status
COMPLETED
Study type
OBSERVATIONAL
HIV-1-infection
Start date
2017-01-01
Primary completion
2018-04-18
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.